Tebentafusp-Tebn

DRUG2 trials

Sponsors

Thomas Jefferson University

Conditions

Locally Advanced Unresectable Uveal MelanomaMetastatic Uveal Melanoma

Phase 1

Tebentafusp-tebn With LDT in Metastatic UM

RecruitingNCT06626516

Thomas Jefferson UniversityMetastatic Uveal Melanoma

Start: 2025-10-15End: 2032-08-31Target: 109Updated: 2025-11-28

Phase 2

Neoadjuvant Tebentafusp for Uveal Melanoma

RecruitingNCT06414590

Thomas Jefferson UniversityLocally Advanced Unresectable Uveal Melanoma

Start: 2025-09-05End: 2032-03-01Target: 19Updated: 2026-03-03

Related Papers

Recent Advancements in Cell-Based Therapies in Melanoma.

2024-09-124 citations